博士論文
ImageImageImage

Real-world efficacy of first-line pembrolizumab in patients with advanced or recurrent non-small cell lung cancer and high PD-L1 tumor expression.

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Real-world efficacy of first-line pembrolizumab in patients with advanced or recurrent non-small cell lung cancer and high PD-L1 tumor expression.

Persistent ID (NDL)
info:ndljp/pid/12071072
Material type
博士論文
Author
丹保, 裕一ほか
Publisher
-
Publication date
2020-06-30
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
金沢大学,博士(医学)
View All

Notes on use at the National Diet Library

Notes on use

Note (General):

博士論文本文Full 以下に掲載:Clinical Lung Cancer 21(5) pp.e366-e379 2020. Elsevier. 共著者:Yuichi Tambo, Takashi Sone, Kazuhiko Shibata, Kouichi Nishi, Hiroki Shira...

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
丹保, 裕一
TAMBO, Yuichi
Publication Date
2020-06-30
Publication Date (W3CDTF)
2020-06-30
Periodical title
博士論文本文Full
Degree grantor/type
金沢大学
Date Granted
2020-06-30
Date Granted (W3CDTF)
2020-06-30